Lenalidomide NEW

Lenalidomide - Product Introduction

Definition: Lenalidomide is an immunomodulatory drug (IMiD) that has anti-cancer, anti-inflammatory, and immunosuppressive properties. It is a derivative of thalidomide and is primarily used to treat hematologic malignancies and certain autoimmune disorders.

Functions:

· Inhibits the growth of cancer cells by modulating the immune system and inhibiting angiogenesis (the formation of new blood vessels).

· Stimulates the production of immune cells that target and destroy cancer cells.

· Reduces the production of pro-inflammatory cytokines, making it useful in treating certain autoimmune conditions.

· Increases the activity of natural killer (NK) cells and T-cells, enhancing the body's immune response.

Applications:

· Pharmaceutical Industry: Used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and other hematologic malignancies.

· Healthcare: Prescribed for patients with relapsed or refractory multiple myeloma, as well as in certain cases of non-Hodgkin lymphoma and chronic lymphocytic leukemia.

· Research: Investigated for its potential in treating other cancers, autoimmune diseases, and inflammatory conditions.